News & Media
Four MD Anderson researchers elected AAAS Fellows
In recognition of their significant achievements in the realm of cancer care and research, Boyi Gan, Ph.D., Candelaria Gomez-Manzano, M.D., Li Ma, Ph.D., and Sattva Neelapu, M.D., have been elected fellows of the American Association for the Advancement of Science (AAAS). This prestigious distinction stands as one of the highest accolades within the scientific research community.
MD Anderson researchers elected as AAAS Fellows
In honor of their notable contributions to the field of cancer research, Juan Fueyo, M.D., and Victor Prieto, M.D., Ph.D., from The University of Texas MD Anderson Cancer Center, have been named fellows of the American Association for the Advancement of Science (AAAS). Being named an AAAS Fellow is among the highest honors in the scientific research community.
Cancer Research Starts Here: Accelerating Our Understanding of Cancer into the Future (National Cancer Institute)
Much of the recent improvement in 5-year survival rates for all cancers combined is the result of discoveries across the past five decades that have shaped our understanding of what cancer is, its biological and social risk factors, and how it grows and spreads. Thanks to the individuals who perform this research, more lives have been saved and great strides were made in preventing, diagnosing, and treating this collection of diseases.
Read more about fifty years of the National Cancer Act here.
Smart bomb virus shows promise as brain tumor immunotherapy
A common cold virus engineered to attack the most common and deadly of brain tumors allowed 20 percent of patients with recurrent glioblastoma to live for three years or longer, researchers from The University of Texas MD Anderson Cancer Center report on a Phase I clinical trial in the Journal of Clinical Oncology.
Is the common cold the cure for cancer?
Glioblastomas, or malignant gliomas, are sometimes called “grow-and-go” tumors. They make their own blood supply, which fuels the tumors’ rapid growth and helps them hatch satellite tumors. Each tumor sends out tentacles that infiltrate and dig deep into normal brain tissue. Confronting this very aggressive cancer takes a creative approach such as an MD Anderson clinical trial that’s using the common cold virus to battle glioblastoma.
Unleashing the cold virus to kill cancer
MD Anderson researchers are turning the common cold virus into a cancer-seeking missile that attacks brain tumors.